eHealth (EHTH) 10-Q 8 Nov 13 2013 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2013	Oct. 31, 2013
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'EHTH	'
Entity Registrant Name	'eHealth, Inc.	'
Entity Central Index Key	'0001333493	'
Current Fiscal Year End Date	'--12-31	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	18,621,347

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Current Assets:	'		'
Cash and cash equivalents	$97,751		$140,849
Accounts receivable	6,599		4,468
Deferred income taxes	7,115		4,098
Prepaid expenses and other current assets	6,720		6,643
Total current assets	118,185		156,058
Property and equipment, net	10,677		6,185
Deferred income taxes	4,198		2,928
Other assets	6,082		8,123
Intangible assets, net	7,850		8,911
Goodwill	14,096		14,096
Total assets	161,088		196,301
Current Liabilities:	'		'
Accounts payable	4,230		6,123
Accrued compensation and benefits	10,764		8,244
Accrued marketing expenses	3,746		3,941
Deferred revenue	4,353		926
Other current liabilities	2,969		1,575
Total current liabilities	26,062		20,809
Non-current liabilities	6,222		4,625
Stockholders' equity:	'		'
Common stock	28		27
Additional paid-in capital	246,190		232,903
Treasury stock, at cost	-149,998	[1]	-90,991	[1]
Retained earnings	32,424		28,743
Accumulated other comprehensive income	160		185
Total stockholders' equity	128,804		170,867
Total liabilities and stockholders' equity	$161,088		$196,301
[1]	Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.

Condensed_Consolidated_Stateme

Condensed Consolidated Statements Of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue	'	'	'	'
Commission	$36,000	$31,291	$109,193	$93,358
Other	6,008	6,295	15,822	16,810
Total revenue	42,008	37,586	125,015	110,168
Operating costs and expenses:	'	'	'	'
Cost of revenue	806	1,099	4,441	3,538
Marketing and advertising	14,852	13,988	43,448	39,142
Customer care and enrollment	8,936	8,823	23,914	21,152
Technology and content	9,117	5,503	23,585	16,018
General and administrative	7,540	6,744	22,191	19,938
Amortization of intangible assets	354	354	1,061	1,261
Total operating costs and expenses	41,605	36,511	118,640	101,049
Income from operations	403	1,075	6,375	9,119
Other income (expense), net	-22	4	-68	41
Income before provision for income taxes	381	1,079	6,307	9,160
Provision for income taxes	207	874	2,626	4,525
Net income	174	205	3,681	4,635
Net Income Per Share:	'	'	'	'
Basic	$0.01	$0.01	$0.19	$0.24
Diluted	$0.01	$0.01	$0.18	$0.23
Weighted-average number of shares used in per share amounts:	'	'	'	'
Basic	18,436	19,970	19,310	19,711
Diluted	19,096	20,750	19,912	20,563
Comprehensive income:	'	'	'	'
Foreign currency translation adjustment	-7	3	-25	1
Comprehensive income	$167	$208	$3,656	$4,636

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements Of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Operating activities	'	'
Net income	$3,681	$4,635
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Deferred income taxes	-3,951	15
Depreciation and amortization	2,290	1,740
Amortization of book-of-business consideration	2,822	1,990
Amortization of intangible assets	1,061	1,261
Stock-based compensation expense	5,361	4,326
Deferred rent and other	917	51
Changes in operating assets and liabilities:	'	'
Accounts receivable	-2,131	4,799
Prepaid expenses and other assets	-852	-656
Accounts payable	-1,895	2,180
Accrued compensation and benefits	2,504	913
Accrued marketing expenses	-196	-2,332
Deferred revenue	3,794	390
Other current liabilities	1,370	341
Net cash provided by operating activities	14,775	19,653
Investing activities	'	'
Purchases of property and equipment	-6,735	-3,128
Consideration paid in connection with book-of-business transfers	'	-6,243
Net cash used in investing activities	-6,735	-9,371
Financing activities	'	'
Proceeds from exercise of common stock options	4,650	4,014
Cash used to net-share settle equity awards	-940	-991
Excess tax benefits from stock-based compensation	4,217	2,358
Repurchase of common stock	-59,007	-8,441
Principal payments in connection with capital leases	-41	-31
Net cash used in financing activities	-51,121	-3,091
Effect of exchange rate changes on cash and cash equivalents	-17	2
Net decrease in cash and cash equivalents	-43,098	7,193
Cash and cash equivalents at beginning of period	140,849	123,607
Cash and cash equivalents at end of period	$97,751	$130,800

Summary_Of_Business_And_Signif

Summary Of Business And Significant Accounting Policies	9 Months Ended
	Sep. 30, 2013
Summary Of Business And Significant Accounting Policies [Abstract]	'
Summary Of Business And Significant Accounting Policies	'
	Note 1 - Summary of Business and Significant Accounting Policies
	Description of Business—eHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (www.eHealth.com,  www.eHealthInsurance.com,  www.eHealthMedicare.com and www.PlanPrescriber.com), consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all 50 states and the District of Columbia.
	Basis of Presentation—The accompanying condensed consolidated balance sheet as of September 30, 2013, the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2012 and 2013 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2012 and 2013, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2012 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2012, which was filed with the Securities and Exchange Commission on March 13, 2013. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K.
	The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2012, and include all adjustments necessary for the fair presentation of eHealth’s statement of financial position as of September 30, 2013, its results of operations for the three and nine months ended September 30, 2012 and 2013 and its cash flows for the nine months ended September 30, 2012 and 2013. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December 31, 2013.
	Seasonality—The number of individual and family health insurance applications submitted through our ecommerce platform has generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. Conversely, we have generally experienced a decline or flattening of individual and family submitted applications in our second quarter compared to our first quarter and in our fourth quarter compared to our third quarter. This seasonality could change in the fourth quarter of 2013 as a result of the initial open enrollment period under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act, which began on October 1, 2013 and is scheduled to run through March 31, 2014.
	The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies sold during the annual enrollment period typically renew on January 1 of each year.
	Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by these patterns. As a result, marketing and advertising expenses related to individual and family health insurance plans have been highest in our first and third quarters, while marketing and advertising expenses related to Medicare-related plans have been highest in our third and fourth quarters. However, the historical trend of marketing and advertising expenses related to individual and family health insurance plans could be impacted by the initial open enrollment period for individual and family plans that began on October 1, 2013.
	Additionally, in preparation for the Medicare annual enrollment period, and to a lesser extent the initial open enrollment period for individual and family plans, we begin ramping up our customer care center staff during our second and third quarters to handle the anticipated increased volume of health insurance transactions during the fourth quarter. Accordingly, our customer care center staffing costs are significantly higher in our third and fourth quarters compared to our first and second quarters.
	Recently Adopted Accounting Standards—Effective January 1, 2013, we adopted an accounting standards update with new guidance on the presentation of reclassifications from accumulated other comprehensive income to net income. This standard requires an entity to present reclassifications from accumulated other comprehensive income to net income either on the face of the condensed consolidated financial statements or in the notes to the condensed consolidated financial statements. In the nine months ended September 30, 2013 we did not have any reclassifications from accumulated other comprehensive income to net income.

Cash_Cash_Equivalents_And_Acco

Cash, Cash Equivalents And Accounts Receivable	9 Months Ended
	Sep. 30, 2013
Cash, Cash Equivalents And Accounts Receivable [Abstract]	'
Cash, Cash Equivalents And Accounts Receivable	'
	Note 2 – Cash, Cash Equivalents and Accounts Receivable
	Cash and Cash Equivalents—As of December 31, 2012 and September 30, 2013, our cash equivalents consisted of money market accounts that invested in U.S. government-sponsored enterprise bonds and discount notes, U.S. government treasury bills and notes and repurchase agreements collateralized by U.S. government obligations. At December 31, 2012 and September 30, 2013, our cash equivalents carried no unrealized gains or losses and we did not realize any significant gains or losses on sales of cash equivalents during the three and nine months ended September 30, 2012 and 2013.
	As of December 31, 2012 and September 30, 2013, our cash and cash equivalent balances were invested as follows (in thousands):
		31-Dec-12		30-Sep-13
	Cash	$	27,484	$	19,632
	Money market funds		113,365		78,119
	Total cash and cash equivalents	$	140,849	$	97,751
	We used observable prices in active markets in determining the classification of our money market funds as Level 1 as of December 31, 2012 and September 30, 2013.
	Accounts Receivable—As of December 31, 2012 and September 30, 2013, our accounts receivable consisted of the following (in thousands):
		31-Dec-12		30-Sep-13
	Accounts receivable - from other revenues	$	3,319	$	3,340
	Commissions receivable		1,149		3,259
	Total accounts receivable	$	4,468	$	6,599

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2013
Stockholders' Equity [Abstract]	'
Stockholders' Equity	'
	Note 3 – Stockholders’ Equity
	Stock Plans—The following table summarizes activity under our 2006 Equity Incentive Plan, 1998 Stock Plan and 2005 Stock Plan (collectively, the “Stock Plans”) (in thousands):
		Shares Available for Grant (1)
	Shares available for grant December 31, 2012	3,982
	Additional shares authorized (2)	818
	Restricted stock units granted	-564
	Options granted	-119
	Restricted stock units cancelled	21
	Options cancelled	72
	Shares available for grant September 30, 2013	4,210
	-1	Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so.
	-2	On January 1, 2013, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.
	The following table summarizes stock option activity under the Stock Plans (in thousands, except per share amounts and weighted average remaining contractual life data):
		Number of Stock Options		Weighted Average Exercise Price			Weighted-Average Remaining Contractual Life (years)		Aggregate Intrinsic Value (1)
	Balance outstanding at December 31, 2012	2,956		$	13.41		3.91		$	41,642
	Granted	119		$	21.18
	Exercised	-834		$	5.57
	Cancelled	-72		$	18.52
	Balance outstanding at September 30, 2013	2,169		$	16.68		4.21		$	33,784
	Vested and expected to vest at September 30, 2013	2,108		$	16.65		4.17		$	32,911
	Exercisable at September 30, 2013	1,389		$	16.14		3.48		$	22,389
	-1	The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 and the exercise price of in-the-money options as of those dates.
	The total grant date fair value of stock options vested during the three and nine months ended September 30, 2012 was $0.5 million and $1.9 million, respectively. The total grant date fair value of stock options vested during the three and nine months ended September 30, 2013 was $0.7 million and $2.6 million, respectively.
	The following table summarizes restricted stock unit activity, including performance-based restricted stock unit activity, under the Stock Plans (in thousands, except weighted average remaining contractual life data):
		Number Outstanding		Weighted-Average Remaining Contractual Life (years)		Aggregate Intrinsic Value (1)
	Balance outstanding as of December 31, 2012	381		2.22		$	10,464
	Granted	564
	Vested	-172
	Cancelled	-21
	Balance outstanding as of September 30, 2013	752		2.55		$	24,248
	-1	The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 multiplied by the number of restricted stock units outstanding as of December 31, 2012 and September 30, 2013, respectively.
	The fair value of the restricted stock units is based on eHealth’s stock price on the date of grant, and compensation expense related to these awards is recognized on a straight-line basis over the vesting period. The fair value of performance-based restricted stock units is based on eHealth’s stock price on the date of grant, and compensation expense related to these awards is recognized on an accelerated basis over the vesting period. The total grant date fair value of restricted stock units vested during the nine months ended September 30, 2012 was $3.7 million. The total grant date fair value of restricted stock units vested during the three months ended September 30, 2012 was not material. The total grant date fair value of restricted stock units vested during the three and nine months ended September 30, 2013 was $0.2 million and $3.5 million, respectively.
	Stock Repurchase Programs—On September 10, 2012, we announced that our board of directors approved a stock repurchase program authorizing us to purchase up to $30 million of our common stock and on March 6, 2013, we announced that our board of directors increased the approved repurchase amount under this program to $60 million. Purchases under this program were made in the open market and complied with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The cost of the repurchased shares was funded from available working capital.
	For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method.
	Stock repurchase activity under our stock repurchase programs during the nine months ended September 30, 2013 is summarized as follows (dollars in thousands, except share and per share amounts):
		Total Number of Shares Purchased		Average Price Paid per Share (2)			Amount of Repurchase
	Cumulative balance at December 31, 2012 (1)	6,397,803		$	14.22		$	90,991
	Repurchases of common stock	2,911,466		$	20.27			59,007
	Cumulative balance at September 30, 2013 (1)	9,309,269		$	16.11		$	149,998
	-1	Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.
	(2)Average price paid per share includes commissions.
	In addition to the shares repurchased under our repurchase programs as of September 30, 2013, we have in treasury 209,925 shares that were previously surrendered by employees to satisfy tax withholdings due in connection with the vesting of certain restricted stock units. As of December 31, 2012 and September 30, 2013, we had a total of 6,556,303 shares and 9,519,194 shares, respectively, held in treasury.
	Stock-Based Compensation—The fair value of stock options granted to employees for the three and nine months ended September 30, 2012 and 2013 was estimated using the following weighted average assumptions:
		Three Months Ended September 30,						Nine Months Ended September 30,
		2012			2013			2012			2013
	Expected term		4.6 years			4.3 years			4.7 years			4.3 years
	Expected volatility		43.3%			39.8%			44.3%			39.7%
	Expected dividend yield		0%			0%			0%			0%
	Risk-free interest rate		0.61%			1.13%			0.90%			0.79%
	Weighted-average fair value	$	6.46		$	8.39		$	6.41		$	7.02
	The following table summarizes stock-based compensation expense recorded during the three and nine months ended September 30, 2012 and 2013 (in thousands):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2012			2013			2012			2013
	Common stock options	$	717		$	654		$	2,076		$	2,103
	Restricted stock units		622			1,291			2,250			3,258
	Total stock-based compensation expense	$	1,339		$	1,945		$	4,326		$	5,361
	The following table summarizes stock-based compensation expense by operating function for the three and nine months ended September 30, 2012 and 2013 (in thousands):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2012			2013			2012			2013
	Marketing and advertising	$	330		$	517		$	932		$	1,446
	Customer care and enrollment		90			92			243			261
	Technology and content		233			425			783			1,129
	General and administrative		686			911			2,368			2,525
Total stock-based compensation expense	$	1,339		$	1,945		$	4,326		$	5,361

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2013
Income Taxes [Abstract]	'
Income Taxes	'
	Note 4 – Income Taxes
	The following table summarizes our provision for income taxes and our effective tax rates for the three and nine months ended September 30, 2012 and 2013 (in thousands, except effective tax rate):
		Three Months Ended September 30,				Nine Months Ended September 30,
		2012		2013		2012		2013
	Income before provision for income taxes	$	1,079	$	381	$	9,160	$	6,307
	Provision for income taxes	$	874	$	207	$	4,525	$	2,626
	Effective tax rate		81.0%		54.3%		49.4%		41.6%
	Our effective tax rate in the three and nine months ended September 30, 2012 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses and tax shortfalls related to share-based payments. Our effective tax rate in the three and nine months ended September 30, 2013 was higher than statutory federal and state tax rates due primarily to non-deductible lobbying expenses, partially offset by a tax benefit resulting from the recent extension of the federal research tax credit through December 31, 2013.
	During the three and nine months ended September 30, 2012, we utilized excess federal and state tax benefits related to share-based payments, which resulted in increases of $1.2 million and $2.4 million, respectively, in Additional Paid-In Capital in the condensed consolidated balance sheets. During the three and nine months ended September 30, 2013, we utilized excess federal and state tax benefits related to share-based payments, which resulted in increases of $0.3 million and $4.2 million, respectively, in Additional Paid-In Capital in the condensed consolidated balance sheets. These amounts are also classified in the condensed consolidated statements of cash flows as both a reduction to operating cash flows and as a financing cash inflow.

Net_Income_Per_Share

Net Income Per Share	9 Months Ended
	Sep. 30, 2013
Net Income Per Share [Abstract]	'
Net Income Per Share	'
	Note 5 – Net Income Per Share
	Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding for the period (excluding shares subject to repurchase). Diluted net income per share is computed by dividing the net income for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net income per share is computed giving effect to all potential dilutive common stock equivalent shares, including options, restricted stock and restricted stock units. The dilutive effect of outstanding awards is reflected in diluted net income per share by application of the treasury stock method.
	The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share amounts):
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2012			2013		2012		2013
	Basic:
	Numerator:
	Net income allocated to common stock	$	205		$	174	$	4,635	$	3,681
	Denominator:
	Net weighted average number of common stock shares outstanding		19,970			18,436		19,711		19,310
	Net income per share—basic:	$	0.01		$	0.01	$	0.24	$	0.19
	Diluted:
	Numerator:
	Net income allocated to common stock	$	205		$	174	$	4,635	$	3,681
	Denominator:
	Net weighted average number of common stock shares outstanding		19,970			18,436		19,711		19,310
	Weighted average number of options		703			528		750		478
	Weighted average number of restricted stock units		77			132		102		124
	Total common stock shares used in per share calculation		20,750			19,096		20,563		19,912
	Net income per share—diluted:	$	0.01		$	0.01	$	0.23	$	0.18
	For each of the three- and nine- month periods ended September 30, 2012 and 2013, we had securities outstanding that could potentially dilute net income per share, but the shares from the assumed exercise of these securities were excluded in the computation of diluted net income per share as their effect would have been anti-dilutive. The number of outstanding weighted average anti-dilutive shares that were excluded from the computation of diluted net income per share consisted of the following (in thousands):
		Three Months Ended September 30,				Nine Months Ended September 30,
		2012		2013		2012	2013
	Common stock options	1,484		127		1,327	439
	Total	1,484		127		1,327	439

Geographic_Information_And_Sig

Geographic Information And Significant Customers	9 Months Ended
	Sep. 30, 2013
Geographic Information And Significant Customers [Abstract]	'
Geographic Information And Significant Customers	'
	Note 6 – Geographic Information and Significant Customers
	Geographic Information—As of December 31, 2012 and September 30, 2013, our long-lived assets consisted primarily of property and equipment, goodwill and other indefinite-lived intangible assets and finite-lived intangible assets. Our long-lived assets are attributed to the geographic location in which they are located. Long-lived assets by geographical area were as follows (in thousands):
		As of			As of
		31-Dec-12			30-Sep-13
	United States	$	37,037		$	38,363
	China		278			342
	Total	$	37,315		$	38,705
	Significant Customers—Substantially all revenue for the three and nine months ended September 30, 2012 and 2013 was generated from customers located in the United States. Carriers representing 10% or more of our total revenue in the three and nine months ended September 30, 2012 and 2013 are presented in the table below:
		Three Months Ended September 30,				Nine Months Ended September 30,
		2012		2013		2012	2013
	Humana	19%		18%		16%	20%
	WellPoint (1)	13%		12%		13%	12%
	UnitedHealthcare (2)	12%		11%		13%	11%
	Aetna (3)	7%		10%		7%	9%
	-1	Wellpoint also includes other carriers owned by Wellpoint.
	-2	UnitedHealthcare also includes other carriers owned by UnitedHealthcare.
	-3	Aetna also includes other carriers owned by Aetna.
	Commission revenue attributable to major medical individual and family health insurance plans was approximately 79% and 78% of our commission revenue in the three and nine months ended September 30, 2012, respectively. Commission revenue attributable to major medical individual and family health insurance plans was approximately 74% and 72% of our commission revenue in the three and nine months ended September 30, 2013, respectively. We define our individual and family plan offerings as major medical individual and family health insurance plans, which do not include small business, Medicare-related health insurance plan offerings and other ancillary products such as short-term, stand-alone dental, life, vision, accident and student insurance plan offerings.
	As of December 31, 2012, four customers represented 25%,  22%, 14% and 11%, respectively, for a combined total of 72% of our $4.5 million outstanding accounts receivable balance. As of September 30, 2013, two customers represented 43%  and 33%, respectively of our $6.6 million outstanding accounts receivable balance. No other customers represented 10% or more of our total accounts receivable at December 31, 2012 and September 30, 2013. We believe the potential for collection issues with any of our customers is minimal as of September 30, 2013. Accordingly, our estimate for uncollectible amounts at September 30, 2013 was not material.

Summary_Of_Business_And_Signif1

Summary Of Business And Significant Accounting Policies (Policy)	9 Months Ended
	Sep. 30, 2013
Summary Of Business And Significant Accounting Policies [Abstract]	'
Description Of Business	'
	Description of Business—eHealth, Inc. (the “Company,” “eHealth,” “we” or “us”) is the leading online source of health insurance for individuals, families and small businesses in the United States. Through our website addresses (www.eHealth.com,  www.eHealthInsurance.com,  www.eHealthMedicare.com and www.PlanPrescriber.com), consumers can get quotes from leading health insurance carriers, compare plans side-by-side, and apply for and purchase individual and family, Medicare-related, small business and ancillary health insurance plans. We actively market the availability of Medicare-related insurance plans and offer Medicare plan comparison tools and educational materials for Medicare-related insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans.  Our ecommerce technology also enables us to deliver consumers’ health insurance applications electronically to health insurance carriers. As a result, we simplify and streamline the complex and traditionally paper-intensive health insurance sales and purchasing process. We are licensed to market and sell health insurance in all 50 states and the District of Columbia.
Basis Of Presentation	'
	Basis of Presentation—The accompanying condensed consolidated balance sheet as of September 30, 2013, the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, 2012 and 2013 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2012 and 2013, respectively, are unaudited. The condensed consolidated balance sheet data as of December 31, 2012 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2012, which was filed with the Securities and Exchange Commission on March 13, 2013. The accompanying statements should be read in conjunction with the audited consolidated financial statements and related notes contained in our Annual Report on Form 10-K.
	The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2012, and include all adjustments necessary for the fair presentation of eHealth’s statement of financial position as of September 30, 2013, its results of operations for the three and nine months ended September 30, 2012 and 2013 and its cash flows for the nine months ended September 30, 2012 and 2013. All adjustments are of a normal recurring nature. The results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results to be expected for any subsequent period or for the fiscal year ending December 31, 2013.
Seasonality	'
	Seasonality—The number of individual and family health insurance applications submitted through our ecommerce platform has generally increased in our first quarter compared to our fourth quarter and in our third quarter compared to our second quarter. Conversely, we have generally experienced a decline or flattening of individual and family submitted applications in our second quarter compared to our first quarter and in our fourth quarter compared to our third quarter. This seasonality could change in the fourth quarter of 2013 as a result of the initial open enrollment period under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act, which began on October 1, 2013 and is scheduled to run through March 31, 2014.
	The majority of Medicare plans are sold in our fourth quarter during the Medicare annual enrollment period, when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, we generate a significant amount of Medicare plan-related revenue in the fourth quarter of the year resulting from the sale of new Medicare plans. Additionally, we recognize a majority of our renewal Medicare Advantage and Medicare Part D prescription drug plan commission revenue in the first quarter of each year as the majority of policies sold during the annual enrollment period typically renew on January 1 of each year.
	Since a significant portion of our marketing and advertising expenses are driven by the number of health insurance applications submitted on our ecommerce platform, those expenses are influenced by these patterns. As a result, marketing and advertising expenses related to individual and family health insurance plans have been highest in our first and third quarters, while marketing and advertising expenses related to Medicare-related plans have been highest in our third and fourth quarters. However, the historical trend of marketing and advertising expenses related to individual and family health insurance plans could be impacted by the initial open enrollment period for individual and family plans that began on October 1, 2013.
	Additionally, in preparation for the Medicare annual enrollment period, and to a lesser extent the initial open enrollment period for individual and family plans, we begin ramping up our customer care center staff during our second and third quarters to handle the anticipated increased volume of health insurance transactions during the fourth quarter. Accordingly, our customer care center staffing costs are significantly higher in our third and fourth quarters compared to our first and second quarters.
Recently Adopted Accounting Standards	'
	Recently Adopted Accounting Standards—Effective January 1, 2013, we adopted an accounting standards update with new guidance on the presentation of reclassifications from accumulated other comprehensive income to net income. This standard requires an entity to present reclassifications from accumulated other comprehensive income to net income either on the face of the condensed consolidated financial statements or in the notes to the condensed consolidated financial statements. In the nine months ended September 30, 2013 we did not have any reclassifications from accumulated other comprehensive income to net income.

Cash_Cash_Equivalents_And_Acco1

Cash, Cash Equivalents And Accounts Receivable (Tables)	9 Months Ended
	Sep. 30, 2013
Cash, Cash Equivalents And Accounts Receivable [Abstract]	'
Schedule Of Cash And Cash Equivalents	'
		31-Dec-12		30-Sep-13
	Cash	$	27,484	$	19,632
	Money market funds		113,365		78,119
	Total cash and cash equivalents	$	140,849	$	97,751
Schedule Of Accounts Receivable	'
		31-Dec-12		30-Sep-13
	Accounts receivable - from other revenues	$	3,319	$	3,340
	Commissions receivable		1,149		3,259
	Total accounts receivable	$	4,468	$	6,599

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2013
Stockholders' Equity [Abstract]	'
Schedule Of Shares Available For Grant	'
		Shares Available for Grant (1)
	Shares available for grant December 31, 2012	3,982
	Additional shares authorized (2)	818
	Restricted stock units granted	-564
	Options granted	-119
	Restricted stock units cancelled	21
	Options cancelled	72
	Shares available for grant September 30, 2013	4,210
	-1	Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so.
	-2	On January 1, 2013, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.
Schedule Of Option Activity Under Stock Plans	'
		Number of Stock Options		Weighted Average Exercise Price			Weighted-Average Remaining Contractual Life (years)		Aggregate Intrinsic Value (1)
	Balance outstanding at December 31, 2012	2,956		$	13.41		3.91		$	41,642
	Granted	119		$	21.18
	Exercised	-834		$	5.57
	Cancelled	-72		$	18.52
	Balance outstanding at September 30, 2013	2,169		$	16.68		4.21		$	33,784
	Vested and expected to vest at September 30, 2013	2,108		$	16.65		4.17		$	32,911
	Exercisable at September 30, 2013	1,389		$	16.14		3.48		$	22,389
	-1	The aggregate intrinsic value is calculated as the difference between eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 and the exercise price of in-the-money options as of those dates.
Schedule Of Restricted Stock Unit Activity Under Stock Plans	'
		Number Outstanding		Weighted-Average Remaining Contractual Life (years)		Aggregate Intrinsic Value (1)
	Balance outstanding as of December 31, 2012	381		2.22		$	10,464
	Granted	564
	Vested	-172
	Cancelled	-21
	Balance outstanding as of September 30, 2013	752		2.55		$	24,248
	-1	The aggregate intrinsic value is calculated as eHealth’s closing stock price as of December 31, 2012 and September 30, 2013 multiplied by the number of restricted stock units outstanding as of December 31, 2012 and September 30, 2013, respectively.
Schedule Of Stock Repurchase Activity Under Stock Repurchase Programs	'
		Total Number of Shares Purchased		Average Price Paid per Share (2)			Amount of Repurchase
	Cumulative balance at December 31, 2012 (1)	6,397,803		$	14.22		$	90,991
	Repurchases of common stock	2,911,466		$	20.27			59,007
	Cumulative balance at September 30, 2013 (1)	9,309,269		$	16.11		$	149,998
	-1	Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.
	(2)Average price paid per share includes commissions.
Schedule Of Fair Value Of Stock Options, Valuation Assumptions	'
		Three Months Ended September 30,						Nine Months Ended September 30,
		2012			2013			2012			2013
	Expected term		4.6 years			4.3 years			4.7 years			4.3 years
	Expected volatility		43.3%			39.8%			44.3%			39.7%
	Expected dividend yield		0%			0%			0%			0%
	Risk-free interest rate		0.61%			1.13%			0.90%			0.79%
	Weighted-average fair value	$	6.46		$	8.39		$	6.41		$	7.02
Schedule Of Stock-Based Compensation Expense	'
	The following table summarizes stock-based compensation expense recorded during the three and nine months ended September 30, 2012 and 2013 (in thousands):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2012			2013			2012			2013
	Common stock options	$	717		$	654		$	2,076		$	2,103
	Restricted stock units		622			1,291			2,250			3,258
	Total stock-based compensation expense	$	1,339		$	1,945		$	4,326		$	5,361
	The following table summarizes stock-based compensation expense by operating function for the three and nine months ended September 30, 2012 and 2013 (in thousands):
		Three Months Ended September 30,						Nine Months Ended September 30,
		2012			2013			2012			2013
	Marketing and advertising	$	330		$	517		$	932		$	1,446
	Customer care and enrollment		90			92			243			261
	Technology and content		233			425			783			1,129
	General and administrative		686			911			2,368			2,525
	Total stock-based compensation expense	$	1,339		$	1,945		$	4,326		$	5,361

Income_Taxes_Tables

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2013
Income Taxes [Abstract]	'
Summary Of Provision For Income Taxes And Effective Tax Rates	'
		Three Months Ended September 30,				Nine Months Ended September 30,
		2012		2013		2012		2013
	Income before provision for income taxes	$	1,079	$	381	$	9,160	$	6,307
	Provision for income taxes	$	874	$	207	$	4,525	$	2,626
	Effective tax rate		81.0%		54.3%		49.4%		41.6%

Net_Income_Per_Share_Tables

Net Income Per Share (Tables)	9 Months Ended
	Sep. 30, 2013
Net Income Per Share [Abstract]	'
Schedule Of Computation Of Basic And Diluted Net Income Per Share	'
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2012			2013		2012		2013
	Basic:
	Numerator:
	Net income allocated to common stock	$	205		$	174	$	4,635	$	3,681
	Denominator:
	Net weighted average number of common stock shares outstanding		19,970			18,436		19,711		19,310
	Net income per share—basic:	$	0.01		$	0.01	$	0.24	$	0.19
	Diluted:
	Numerator:
	Net income allocated to common stock	$	205		$	174	$	4,635	$	3,681
	Denominator:
	Net weighted average number of common stock shares outstanding		19,970			18,436		19,711		19,310
	Weighted average number of options		703			528		750		478
	Weighted average number of restricted stock units		77			132		102		124
	Total common stock shares used in per share calculation		20,750			19,096		20,563		19,912
	Net income per share—diluted:	$	0.01		$	0.01	$	0.23	$	0.18
Schedule Of Anti-dilutive Shares Excluded From Computation Of Net Income Per Share	'
		Three Months Ended September 30,				Nine Months Ended September 30,
		2012		2013		2012	2013
	Common stock options	1,484		127		1,327	439
	Total	1,484		127		1,327	439

Geographic_Information_And_Sig1

Geographic Information And Significant Customers (Tables)	9 Months Ended
	Sep. 30, 2013
Geographic Information And Significant Customers [Abstract]	'
Schedule Of Long Lived Assets By Geographical Areas	'
		As of			As of
		31-Dec-12			30-Sep-13
	United States	$	37,037		$	38,363
	China		278			342
	Total	$	37,315		$	38,705
Schedule of Revenue by Major Customers	'
		Three Months Ended September 30,				Nine Months Ended September 30,
		2012		2013		2012	2013
	Humana	19%		18%		16%	20%
	WellPoint (1)	13%		12%		13%	12%
	UnitedHealthcare (2)	12%		11%		13%	11%
	Aetna (3)	7%		10%		7%	9%
	-1	Wellpoint also includes other carriers owned by Wellpoint.
	-2	UnitedHealthcare also includes other carriers owned by UnitedHealthcare.
	-3	Aetna also includes other carriers owned by Aetna.

Summary_Of_Business_And_Signif2

Summary Of Business And Significant Accounting Policies (Details)	Sep. 30, 2013
	state
Summary Of Business And Significant Accounting Policies [Abstract]	'
Number of states in which the Company is licensed to market and sell health insurance	50

Cash_Cash_Equivalents_And_Acco2

Cash, Cash Equivalents And Accounts Receivable (Schedule Of Cash And Cash Equivalents) (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Cash, Cash Equivalents And Accounts Receivable [Abstract]	'	'	'	'
Cash	$19,632	$27,484	'	'
Money market funds	78,119	113,365	'	'
Total cash and cash equivalents	$97,751	$140,849	$130,800	$123,607

Cash_Cash_Equivalents_And_Acco3

Cash, Cash Equivalents And Accounts Receivable (Schedule Of Accounts Receivable) (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Cash, Cash Equivalents And Accounts Receivable [Abstract]	'	'
Accounts receivable - from other revenues	$3,340	$3,319
Commissions receivable	3,259	1,149
Total accounts receivable	$6,599	$4,468

Stockholders_Equity_Details

Stockholders' Equity (Details) (USD $)	0 Months Ended	3 Months Ended		9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 10, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Stockholders' Equity [Abstract]	'	'	'	'	'	'
Total grant date fair value of stock options vested	'	$0.70	$0.50	$2.60	$1.90	'
Total grant date fair value of restricted stock units vested	'	0.2	'	3.5	3.7	'
Stock repurchase program, authorized amount	$30	'	'	$60	'	'
Shares surrendered by employees to satisfy tax withholdings	'	209,925	'	209,925	'	'
Treasury stock, number of shares held	'	9,519,194	'	9,519,194	'	6,556,303

Stockholders_Equity_Schedule_O

Stockholders' Equity (Schedule Of Equity Activity) (Details)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013
Stockholders' Equity [Abstract]	'
Shares available for grant December 31, 2012	3,982	[1]
Additional shares authorized	818	[1],[2]
Restricted stock units granted	-564	[1]
Options granted	-119	[1]
Restricted stock units cancelled	21	[1]
Options cancelled	72	[1]
Shares available for grant September 30, 2013	4,210	[1]
[1]	Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so.
[2]	On JanuaryB 1, 2013, the number of shares authorized for issuance under the 2006 Equity Incentive Plan was automatically increased pursuant to the terms of the 2006 Equity Incentive Plan.

Stockholders_Equity_Schedule_O1

Stockholders' Equity (Schedule Of Option Activity Under Stock Plans) (Details) (USD $)	9 Months Ended		12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013		Dec. 31, 2012
Stockholders' Equity [Abstract]	'		'
Number of Stock Options, Balance outstanding at December 31, 2012	2,956		'
Number of Stock Options, Granted	119	[1]	'
Number of Stock Options, Exercised	-834		'
Number of Stock Options, Cancelled	-72	[1]	'
Number of Stock Options, Balance outstanding at September 30, 2013	2,169		2,956
Number of Stock Options, Vested and expected to vest at September 30, 2013	2,108		'
Number of Stock Options, Exercisable at September 30, 2013	1,389		'
Weighted Average Exercise Price, Balance outstanding at December 31, 2012	$13.41		'
Weighted Average Exercise Price, Granted	$21.18		'
Weighted Average Exercise Price, Exercised	$5.57		'
Weighted Average Exercise Price, Cancelled	$18.52		'
Weighted Average Exercise Price, Balance outstanding at September 30, 2013	$16.68		$13.41
Weighted Average Exercise Price, Vested and expected to vest at September 30, 2013	$16.65		'
Weighted Average Exercise Price, Exercisable at September 30, 2013	$16.14		'
Weighted-Average Remaining Contractual Life (years), Balance outstanding at December 31, 2012	'4 years 2 months 16 days		'3 years 10 months 28 days
Weighted-Average Remaining Contractual Life (years), Balance outstanding at September 30, 2013	'4 years 2 months 16 days		'3 years 10 months 28 days
Weighted-Average Remaining Contractual Life (years), Vested and expected to vest at September 30, 2013	'4 years 2 months 1 day		'
Weighted-Average Remaining Contractual Life (years), Exercisable at September 30, 2013	'3 years 5 months 23 days		'
Aggregate Intrinsic Value, Balance outstanding at December 31, 2012	$41,642	[2]	'
Aggregate Intrinsic Value, Balance outstanding at September 30, 2013	33,784	[2]	41,642	[2]
Aggregate Intrinsic Value, Vested and expected to vest at September 30, 2013	32,911	[2]	'
Aggregate Intrinsic Value, Exercisable at September 30, 2013	$22,389	[2]	'
[1]	Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so.
[2]	The aggregate intrinsic value is calculated as the difference between eHealthbs closing stock price as of December 31, 2012 and September 30, 2013 and the exercise price of in-the-money options as of those dates.

Stockholders_Equity_Schedule_O2

Stockholders' Equity (Schedule Of Restricted Stock Unit Activity Under Stock Plans) (Details) (USD $)	9 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013		Dec. 31, 2012
Stockholders' Equity [Abstract]	'		'
Number Outstanding, Balance outstanding at December 31, 2012	381		'
Number Outstanding, Granted	564	[1]	'
Number Outstanding, Vested	-172		'
Number Outstanding, Cancelled	-21	[1]	'
Number Outstanding, Balance outstanding at September 30, 2013	752		381
Weighted-Average Remaining Contractual Life (years), Balance outstanding at December 31, 2012	'2 years 6 months 18 days		'2 years 2 months 19 days
Weighted-Average Remaining Contractual Life (years), Balance outstanding at September 30, 2013	'2 years 6 months 18 days		'2 years 2 months 19 days
Aggregate Intrinsic Value, Balance outstanding at December 31, 2012	$10,464	[2]	'
Aggregate Intrinsic Value, Balance outstanding at September 30, 2013	$24,248	[2]	$10,464	[2]
[1]	Shares available for grant do not include treasury stock shares that could also become available for grant if we determined to do so.
[2]	The aggregate intrinsic value is calculated as eHealthbs closing stock price as of December 31, 2012 and September 30, 2013 multiplied by the number of restricted stock units outstanding as of December 31, 2012 and September 30, 2013, respectively.

Stockholders_Equity_Schedule_O3

Stockholders' Equity (Schedule Of Stock Repurchase Activity Under Stock Repurchase Programs) (Details) (USD $)	9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2013
Stockholders' Equity [Abstract]	'
Total Number of Shares Purchased, Cumulative balance at December 31, 2012	6,397,803	[1]
Total Number of Shares Purchased, Repurchases of common stock	2,911,466
Total Number of Shares Purchased, Cumulative balance at September 30, 2013	9,309,269	[1]
Average Price Paid per Share, Cumulative balance at December 31, 2012	$14.22	[1],[2]
Average Price Paid per Share, Repurchases of common stock	$20.27	[2]
Average Price Paid per Share, Cumulative balance at September 30, 2013	$16.11	[1],[2]
Amount of Repurchase, Cumulative balance at December 31, 2012	$90,991	[1]
Amount of Repurchase, Repurchases of common stock	59,007
Amount of Repurchase, Cumulative balance at September 30, 2013	$149,998	[1]
[1]	Cumulative balances at December 31, 2012 and September 30, 2013 consist of shares repurchased in connection with our stock repurchase program announced on September 10, 2012, as well as previous stock repurchase plans announced in 2011, 2010 and 2008.
[2]	Average price paid per share includes commissions.

Stockholders_Equity_Schedule_O4

Stockholders' Equity (Schedule Of Fair Value Of Stock Options, Valuation Assumptions) (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Stockholders' Equity [Abstract]	'	'	'	'
Expected term	'4 years 3 months 18 days	'4 years 7 months 6 days	'4 years 3 months 18 days	'4 years 8 months 12 days
Expected volatility	39.80%	43.30%	39.70%	44.30%
Expected dividend yield	0.00%	0.00%	0.00%	0.00%
Risk-free interest rate	1.13%	0.61%	0.79%	0.90%
Weighted-average fair value	$8.39	$6.46	$7.02	$6.41

Stockholders_Equity_Schedule_O5

Stockholders' Equity (Schedule Of Stock-Based Compensation Expense) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Stockholders' Equity [Abstract]	'	'	'	'
Common stock options	$654	$717	$2,103	$2,076
Restricted stock units	1,291	622	3,258	2,250
Total stock-based compensation expense	$1,945	$1,339	$5,361	$4,326

Stockholders_Equity_Schedule_O6

Stockholders' Equity (Schedule Of Stock-Based Compensation Expense By Operating Function) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Total stock-based compensation expense	$1,945	$1,339	$5,361	$4,326
Marketing and Advertising Expense [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Total stock-based compensation expense	517	330	1,446	932
Customer Care And Enrollment Expense [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Total stock-based compensation expense	92	90	261	243
Technology And Content Expense [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Total stock-based compensation expense	425	233	1,129	783
General and Administrative Expense [Member]	'	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'	'
Total stock-based compensation expense	$911	$686	$2,525	$2,368

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Taxes [Abstract]	'	'	'	'
Income before provision for income taxes	$381,000	$1,079,000	$6,307,000	$9,160,000
Provision for income taxes	207,000	874,000	2,626,000	4,525,000
Effective income tax rate	54.30%	81.00%	41.60%	49.40%
Increase in Additional paid-in capital related to excess federal and state tax benefits	$300,000	$1,200,000	$4,200,000	$2,400,000

Net_Income_Per_Share_Schedule_

Net Income Per Share (Schedule Of Computation Of Basic And Diluted Net Income Per Share) (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net Income Per Share [Abstract]	'	'	'	'
Net income allocated to common stock	$174	$205	$3,681	$4,635
Net weighted average number of common stock shares outstanding	18,436	19,970	19,310	19,711
Net income per share-basic:	$0.01	$0.01	$0.19	$0.24
Weighted average number of options	528	703	478	750
Weighted average number of restricted stock units	132	77	124	102
Total common stock equivalent shares used in per share calculation	19,096	20,750	19,912	20,563
Net income per share-diluted:	$0.01	$0.01	$0.18	$0.23

Net_Income_Per_Share_Schedule_1

Net Income Per Share (Schedule Of Anti-dilutive Shares Excluded From Computation Of Net Income Per Share) (Details)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Total	127	1,484	439	1,327
Common Stock Options [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Total	127	1,484	439	1,327

Geographic_Information_And_Sig2

Geographic Information And Significant Customers (Details) (USD $)

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

In Thousands, unless otherwise specified

Commission Revenue [Member]

Commission Revenue [Member]

Commission Revenue [Member]

Commission Revenue [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Accounts Receivable [Member]

Major Medical Individual And Family Insurance Plans [Member]

Major Medical Individual And Family Insurance Plans [Member]

Major Medical Individual And Family Insurance Plans [Member]

Major Medical Individual And Family Insurance Plans [Member]

Customer Concentration Risk [Member]

Customer Concentration Risk [Member]

Customer One [Member]

Customer One [Member]

Customer Two [Member]

Customer Two [Member]

Customer Three [Member]

Customer Four [Member]

customer

customer

Concentration Risk [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of significant customers

'

'

'

'

'

'

4

2

'

'

'

'

'

'

Concentration risk, percentage

'

'

74.00%

79.00%

72.00%

78.00%

72.00%

'

43.00%

25.00%

33.00%

22.00%

14.00%

11.00%

Accounts receivable

$6,599

$4,468

'

'

'

'

'

'

'

'

'

'

'

'

Geographic_Information_And_Sig3

Geographic Information And Significant Customers (Schedule Of Long Lived Assets By Geographical Areas) (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Geographic Information And Significant Customers [Abstract]	'	'
United States	$38,363	$37,037
China	342	278
Total	$38,705	$37,315

Geographic_Information_And_Sig4

Geographic Information And Significant Customers (Schedule Of Revenue By Major Customers) (Details)	3 Months Ended				9 Months Ended
	Sep. 30, 2013		Sep. 30, 2012		Sep. 30, 2013		Sep. 30, 2012
Humana [Member]	'		'		'		'
Revenue, Major Customer [Line Items]	'		'		'		'
Major customer revenue, percentage	18.00%		19.00%		20.00%		16.00%
WellPoint [Member]	'		'		'		'
Revenue, Major Customer [Line Items]	'		'		'		'
Major customer revenue, percentage	12.00%	[1]	13.00%	[1]	12.00%	[1]	13.00%	[1]
UnitedHealthcare [Member]	'		'		'		'
Revenue, Major Customer [Line Items]	'		'		'		'
Major customer revenue, percentage	11.00%	[2]	12.00%	[2]	11.00%	[2]	13.00%	[2]
Aetna [Member]	'		'		'		'
Revenue, Major Customer [Line Items]	'		'		'		'
Major customer revenue, percentage	10.00%	[3]	7.00%	[3]	9.00%	[3]	7.00%	[3]
[1]	Wellpoint also includes other carriers owned by Wellpoint.
[2]	UnitedHealthcare also includes other carriers owned by UnitedHealthcare.
[3]	Aetna also includes other carriers owned by Aetna.